For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| SL-279252 (0.01 mg/kg S1) | 0.01 mg/kg of IV SL-279252 (Schedule 1) | 1 | None | 0 | 1 | 1 | 1 | View |
| SL-279252 (1.0 mg/kg S2) | 1.0 mg/kg of IV SL-279252 (Schedule 2) | 5 | None | 2 | 6 | 5 | 6 | View |
| SL-279252 (0.0001 mg/kg S1) | 0.0001 mg/kg of IV SL-279252 (Schedule 1) | 1 | None | 0 | 1 | 1 | 1 | View |
| SL-279252 (0.001 mg/kg S1) | 0.001 mg/kg of IV SL-279252 (Schedule 1) | 1 | None | 1 | 1 | 1 | 1 | View |
| SL-279252 (0.003 mg/kg S1) | 0.003 mg/kg of IV SL-279252 (Schedule 1) | 2 | None | 0 | 2 | 2 | 2 | View |
| SL-279252 (0.03 mg/kg S1) | 0.03 mg/kg of IV SL-279252 (Schedule 1) | 0 | None | 0 | 2 | 2 | 2 | View |
| SL-279252 (0.1 mg/kg S1) | 0.1 mg/kg of IV SL-279252 (Schedule 1) | 3 | None | 1 | 3 | 3 | 3 | View |
| SL-279252 (0.3 mg/kg S1) | 0.3 mg/kg of IV SL-279252 (Schedule 1) | 4 | None | 1 | 4 | 4 | 4 | View |
| SL-279252 (1.0 mg/kg S1) | 1.0 mg/kg of IV SL-279252 (Schedule 1) | 4 | None | 3 | 6 | 4 | 6 | View |
| SL-279252 (3.0 mg/kg S1) | 3.0 mg/kg of IV SL-279252 (Schedule 1) | 5 | None | 1 | 6 | 6 | 6 | View |
| SL-279252 (6.0 mg/kg S1) | 6.0 mg/kg of IV SL-279252 (Schedule 1) | 4 | None | 1 | 4 | 3 | 4 | View |
| SL-279252 (12.0 mg/kg S1) | 12.0 mg/kg of IV SL-279252 (Schedule 1) | 2 | None | 0 | 4 | 4 | 4 | View |
| SL-279252 (24.0 mg/kg S1) | 24.0 mg/kg of IV SL-279252 (Schedule 1) | 0 | None | 1 | 2 | 2 | 2 | View |
| SL-279252 (0.3 mg/kg S2) | 0.3 mg/kg of IV SL-279252 (Schedule 2) | 2 | None | 0 | 4 | 4 | 4 | View |
| SL-279252 (3.0 mg/kg S2) | 3.0 mg/kg of IV SL-279252 (Schedule 2) | 3 | None | 1 | 3 | 3 | 3 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| infected neoplasm | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| inguinal hernia, obstructive | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| mouth haemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| pleural effusion | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| seizure | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| asthenia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| cerebrovascular accident | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| cholecystitis | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| renal failure | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| subarachnoid haemorrhage | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| acetabulum fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| diffuse large B-cell lymphoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| hemiparesis | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| acute respiratory failure | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| cancer pain | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| haemorrhage intracranial | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| infusion related reaction | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| anaemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| insomnia | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| cough | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| rash maculo-papular | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| dehydration | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| diarrhoea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| dizziness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| asthenia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| neutropenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| non-cardiac chest pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| arthralgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| hyperglycaemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hyperkalaemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hypotension | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| hypothyroidism | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| myalgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| pruritus | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| urinary tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| anxiety | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| cancer pain | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| cerebrovascular accident | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dysgeusia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dyspepsia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| flank pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| hypercalcaemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hypertension | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| hypokalaemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hyponatraemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| influenza like illness | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| neuropathy peripheral | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| night sweats | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| pain in extremity | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| pleural effusion | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| pyrexia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| seizure | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| urinary retention | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| abdominal distension | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| abdominal pain upper | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| anorectal discomfort | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| dysphagia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| faeces discoloured | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| flatulence | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| haematochezia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| large intestinal haemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| odynophagia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| rectal haemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| stomatitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| toothache | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| chest pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| chills | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| face oedema | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| gait disturbance | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| localised oedema | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| oedema peripheral | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| peripheral swelling | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| hyperphosphataemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hypocalcaemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hypomagnesaemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| bone pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| muscular weakness | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| musculoskeletal chest pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| neck pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| sacral pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| anosmia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dyskinesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| paraesthesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dyspnoea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| epistaxis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| oropharyngeal pain | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| pulmonary congestion | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| rhonci | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| sinus pain | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| thoracic haemorrhage | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| thrombocytopenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| thrombocytosis | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| dry skin | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| hyperhidrosis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| skin lesion | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| corneal abrasion | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| procedural pain | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| fall | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| COVID-19 | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| oral candidiasis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| sinusitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| upper respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| delirium | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| deep vein thrombosis | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| flushing | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| haematuria | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| nocturia | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| pollakiuria | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| adrenal insufficiency | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| alanine aminotransferase increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| aspartate aminotransferase increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| blood creatinine increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| blood iron decreased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| weight decreased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| breast pain | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| vaginal haemorrhage | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| atrial fibrillation | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| vertigo | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| eyelid function disorder | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| hyperbilirubinaemia | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| blood creatine increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| decreased appetite | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| back pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |